pharmacie et médicaments – Pénurie de Praluent et de Repatha

This written question asks the French government about the causes and potential solutions for shortages of the cholesterol-lowering drugs Praluent and Repatha. It highlights the impact on patients who rely on these medications for their health. The question seeks information on measures being taken to ensure a stable supply of these drugs and prevent future shortages, affecting patients and healthcare providers.